Plain-English translation of NCT06143488 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a minimally invasive surgical procedure to remove blood clots from the brain — called endovascular therapy — can help people with mild stroke symptoms recover better than standard medical treatment alone. Some patients with mild strokes have a large artery blockage that puts them at high risk of getting worse, even though their initial symptoms seem small. This study wants to know if removing the clot quickly with surgery can prevent that deterioration and improve recovery.
About one-third of people with mild strokes end up with lasting disability, especially when a large artery is blocked. Studies show that without the clot being removed, these patients often get worse within days. This trial exists to find out whether this treatment can safely prevent that worsening and help people recover better.
You likely qualify if…
You likely don't qualify if…
If you qualify and enroll, you will be randomly assigned to one of two groups. One group will receive emergency surgery to remove the blood clot (using techniques like mechanical removal, suction removal, or medication delivered directly to the clot), while the other group will receive standard medical treatment with blood pressure management, clot-preventing medications, and close monitoring. You will have follow-up visits and imaging to check how well you are recovering over the first three months and beyond.
AI-generated summary from trial data · Jul 1, 2026 · Not medical advice
China